Expert FDA Inspection
Preparation & Support

Ensure your facility passes FDA inspections with confidence. Our experienced team provides comprehensive preparation, documentation review, and on-site support.

Don’t wait until the last minute. Our proactive approach ensures your facility is always inspection-ready.

Industries We Serve

Comprehensive FDA Compliance Services

From preparation to post-inspection support, we provide end-to-end solutions to ensure your facility meets all FDA requirements and maintains compliance.

Pre-Inspection Preparation

Comprehensive facility audits, documentation review, and gap analysis to ensure complete readiness.

On-Site Inspection Support

Expert consultants present during inspections to provide guidance and ensure smooth interactions with FDA officials.

CAPA Development

Corrective and Preventive Action plan development for addressing inspection findings and preventing recurrence.

Training Programs

Staff training on FDA regulations, GMP compliance, and inspection preparedness for your entire team.

Documentation Systems

Design and implementation of robust documentation systems that meet FDA requirements and best practices.

24/7 Emergency Support

Round-the-clock support for urgent compliance questions and emergency inspection notifications.

Every facility is unique. We provide tailored consulting services to address your specific compliance challenges and regulatory requirements.

Your Trusted Partner in

FDA Compliance

With over 15 years of experience in FDA regulatory compliance, our team of former FDA inspectors and industry experts has helped hundreds of facilities successfully navigate complex regulatory requirements.

We understand the challenges you face because we’ve been there. Our practical, results-driven approach ensures your facility not only passes inspections but maintains ongoing compliance excellence.

  • Former FDA inspectors on our team with insider knowledge
  • Proven methodologies tested across diverse industries
  • Ongoing support to maintain compliance between inspections

Our team brings decades of combined experience from both regulatory and industry perspectives.

500+

Facilities Served

100%

Success Rate

15+

Years Experience

24/7

Support Available

Our Blogs

A diverse team of software engineers and regulatory auditors in a high-tech data center, analyzing a complex neural network visualization on a glass wall and a transparent digital tablet.
Inspections

How FDA Inspects SaMD and AI-Enabled Medical Device Companies

As artificial intelligence reshapes the medical technology landscape, navigating an AI medical device FDA inspection requires a specialized approach to software validation and algorithmic transparency. This 2026 guide examines how investigators evaluate Software as a Medical Device (SaMD), the importance of Predetermined Change Control Plans (PCCP), and the critical steps for maintaining a state of perpetual audit readiness in a digital-first era.

Read More »
A quality control specialist in a laboratory setting using a transparent digital tablet to inspect a batch of botanical oils on a modern cosmetic assembly line, illustrating MoCRA compliance and facility oversight.
News

FDA Cosmetic Facility Inspections Under MoCRA: What to Expect

The Modernization of Cosmetics Regulation Act (MoCRA) has fundamentally altered the regulatory landscape for the beauty industry. As we enter 2026, cosmetic facilities must prepare for a new era of federal oversight. This guide details what investigators prioritize during MoCRA FDA inspections—from mandatory adverse event reporting to Good Manufacturing Practices (GMP) and safety substantiation—to ensure your facility remains compliant.

Read More »
A corporate director in a professional command center reviewing global inspection data on a transparent tablet, with a large screen in the background displaying a world map and the FDA classifications NAI, VAI, and OAI.
Inspections

High-Traffic Strategic Topics NAI, VAI, and OAI Explained: Understanding FDA Inspection Classifications

Every regulatory audit concludes with a critical final assessment that determines the future of a manufacturing site. This 2026 guide provides an expert breakdown of NAI, VAI, and OAI FDA inspection classifications. Understanding these outcomes is essential for maintaining market access, protecting brand reputation, and navigating the increasingly complex world of life sciences compliance.

Read More »
A specialized robotic arm filling glass vials with biologics inside a high-tech sterile isolator, monitored by a technician in a full cleanroom suit using a transparent data analytics tablet.
Inspections

Top FDA Inspection Findings for Biologics Manufacturing Facilities

As the production of complex large-molecule therapies scales globally, navigating the regulatory hurdles of an audit has never been more challenging. This 2026 guide analyzes the most frequent biologics FDA 483 observations, covering critical areas such as environmental monitoring failures, inadequate viral clearance, and data integrity gaps to help manufacturers maintain a state of constant audit readiness.

Read More »
A robotic gripper performing precision stopper placement on a glass vial within a sterile isolator, while a technician monitors real-time airflow visualization on a transparent digital tablet.
Inspections

FDA Inspection Trends for Sterile Injectable Manufacturing in 2026

As the pharmaceutical industry moves toward advanced aseptic technologies, navigating a sterile manufacturing FDA inspection in 2026 requires a specialized focus on contamination control and automated integrity. This guide explores the latest audit trends—from the impact of Revised Annex 1 to the rise of robotic filling lines—ensuring your facility maintains the highest level of sterility assurance and audit readiness.

Read More »
A sterile medical device manufacturing floor featuring an automated robotic assembly line, technicians in protective gear, and two managers reviewing a "Design Transfer Integrity" digital interface.
Inspections

Top FDA Inspection Risks for Contract Medical Device Manufacturers

Navigating a medical device contract manufacturer FDA inspection requires a rigorous alignment between sponsor expectations and facility operations. As we move into 2026, the risks associated with outsourced manufacturing—ranging from purchasing controls to technical documentation gaps—have intensified. This guide identifies the top inspectional risks and provides a blueprint for maintaining a state of perpetual audit readiness.

Read More »

Get Expert FDA Consultation

Don’t face your next FDA inspection alone. Contact our experts today for a confidential consultation and ensure your facility is ready.

If you’ve received an FDA inspection notice, don’t panic. Our rapid response team can help you prepare quickly and effectively.